Clinical Research Directory
Browse clinical research sites, groups, and studies.
Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy
Sponsor: University of California, San Francisco
Summary
In this randomized controlled trial, 64 participants undergoing PAO at UCSF will be enrolled and randomized to receive either COLP plus treatment as usual (TAU) or TAU alone. Patients in the COLP arm will receive placebo pills alongside prescribed opioids and at scheduled intervals, beginning on postoperative day one. Weekly follow-up will be conducted for six weeks postoperatively via remote surveys and video visits.
Official title: Conditioning, Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy (PAO)
Key Details
Gender
All
Age Range
13 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2026-03
Completion Date
2028-03-31
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Interventions
Open-Label Placebo
One placebo tablet will be taken with each oral opioid dose, 5mg Oxycodone, 6 times per day, beginning on post-operative day 1.
Treatment as usual
Treatment As Usual (TAU) participants will receive their standard opioid dose, 5mg Oxycodone pill, 6 times a day beginning on post-operative day 1.
Locations (1)
University of California San Francisco
San Francisco, California, United States